• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 III; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 III; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Catalog Number 07976836190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/22/2023
Event Type  malfunction  
Manufacturer Narrative
The serial number of the customer's cobas 6000 e601 module is (b)(6).The patient sample was received for investigation.The investigation is ongoing.
 
Event Description
The initial reporter received questionable elecsys ft4 iii and ft3 iii assay results from one patient sample tested on the cobas 6000 e601 module.This medwatch is for the ft4 iii assay.Please refer to a1.Patient identifier (b)(6) for the ft3 iii assay.The initial result was not reported outside of the laboratory.The reporter stated that their laboratory supervisor deemed the results reported by roche cobas e601 did not meet clinical expectations and were unexplainable.They considered that there was an interference in the ft3 & ft4 electrochemiluminescence immunoassays (eclia) that led to the elevated results.The patient sample was sent to two other laboratories: laboratory 1, which uses a beckman dxi 800 analyzer and laboratory 2, which uses an abbott architect.Please refer to the attachment pt-0063963 in the medwatch for the table containing the questionable results.
 
Manufacturer Narrative
The investigation analyzed the patient sample for the presence of interference.The investigation confirmed that the presence of a streptavidin interfering factor in the patient sample led to the elevated elecsys ft3 iii and ft4 iii results.Product labeling states "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination, and other findings.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 III
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17806483
MDR Text Key324109702
Report Number1823260-2023-03075
Device Sequence Number1
Product Code CEC
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
K131244
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07976836190
Device Lot Number67527903
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/29/2023
Initial Date FDA Received09/25/2023
Supplement Dates Manufacturer Received10/25/2023
Supplement Dates FDA Received11/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
METHYL COBALAMIN; METOPROLOL TARTRATE
Patient Age44 YR
Patient SexFemale
-
-